Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-08-18
2010-11-23
Chunduru, Suryaprabha (Department: 1637)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S006120
Reexamination Certificate
active
07838646
ABSTRACT:
The present invention provides novel mutations of the CFTR gene related to cystic fibrosis or to conditions associated with cystic fibrosis. The mutations include duplication of exons including duplication of exons 6b through 10. Methods of identifying if an individual contains the exons 6b through 10 duplication are provided as well as nucleic acid fragments that contain the junction site of the duplicated segment. The detection of additional mutations in the CFTR gene are also provided.
REFERENCES:
patent: 4683194 (1987-07-01), Saiki et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4956778 (1990-09-01), Naito
patent: 4998617 (1991-03-01), Ladd, Jr. et al.
patent: 5130238 (1992-07-01), Malek et al.
patent: 5169766 (1992-12-01), Schuster et al.
patent: 5846710 (1998-12-01), Bajaj
patent: 5885775 (1999-03-01), Haff et al.
patent: 5888819 (1999-03-01), Goelet et al.
patent: 5955377 (1999-09-01), Maul et al.
patent: 5981178 (1999-11-01), Tsui et al.
patent: 5981714 (1999-11-01), Cheng et al.
patent: 6011588 (2000-01-01), Kim
patent: 6288220 (2001-09-01), Kambara et al.
patent: 6355429 (2002-03-01), Nygren et al.
patent: 6403320 (2002-06-01), Read et al.
patent: 6406844 (2002-06-01), Pirrung et al.
patent: 6812339 (2004-11-01), Venter et al.
patent: 2003/0235834 (2003-12-01), Dunlop et al.
patent: 2004/0110138 (2004-06-01), Lem et al.
patent: 2004/0126760 (2004-07-01), Broude
patent: 2005/0059035 (2005-03-01), Huang et al.
patent: 2008/0171332 (2008-07-01), Sun et al.
patent: 0 237362 (1992-03-01), None
patent: 0 329822 (1994-06-01), None
patent: 0 201184 (2004-08-01), None
patent: WO 88/10315 (1988-12-01), None
patent: WO 89/06700 (1989-07-01), None
patent: WO 2004/040013 (2004-05-01), None
Accession No. AY183426, published on Jan. 27, 2003.
Accession No. AF205406, published on Apr. 16, 2004.
Hantash, F. et al. Consultations in Molecular Diagnostics. Characterization of a Recurrent Novel Large Duplication in the Cystic Fibrosis Transmembrane Conductance Regulator Gene. The Journal of Molecular Diagnostics, vol. 9, No. 4, Sep. 2007, p. 556-560.
Ratjen and Doring, Cystic Fibrosis, The Lancet, 361:681-689, 2003.
Audrézet, et al., “Genomic Rearrangements in theCFTRGene: Extensive Allelic Heterogeneity and Diverse Mutational Mechanisms”Hum Mutat.23(4):343-357 (2004).
Boat, et al., “The Metabolic Basis of Inherited Disease”Membrane Transport Systems, 6th ed, 2649-2680 (1989).
Carvalho-Oliveira, et al., “CFTR Localization in Native Airway Cells and Cell Lines Expressing Wild-type of F508del-CFTR by a Panel of Different Antibodies”, Journal of Histochemistry & Cytochemistry, 52(2): 193-203, (2004).
Claass, et al., “Applicability of Different Antibodies for Immunohistochemical Localization of CFTR in Sweat Glands from Healthy Controls and from Patients with Cystic Fibrosis”, The Journal of Histochemistry & Cytochemistry, 48(6): 831-837, (2000).
Cohn, et al., “CFTR: Development of High-Affinity Antibodies and Localization in Sweat Gland”, Biochemical and Biophysical Research Communications, 181(1): 36-43, (1991).
Doucet, et al., “Applicability of Different Antibodies for the Immunohistochemical Localization of CFTR in Respiratory and Intestinal Tissues of Human and Murine Origin”, 51(9): 1191-1199, (2003).
Flanigan, et al., “Rapid Direct Sequence Analysis of the Dystrophin Gene”, Am. J. Genet., 72:931-939, (2003).
Hoogendoorn, et al., “Genotyping Single Nucleotide Polymorphisms by Primer Extension and High Performance Liquid Chromatography”Human Genetics104:89-93 (1999).
Jenison, et al., “Use of a Thin Film Biosensor for Rapid Visual Detection of PCR Products in a Multiplex Format”Biosens Bioelectron16(9-12):757-763 (2001).
Kwoh, et al., “Transcription-Based Amplification System and Detection of Amplified Human Immunodeficiency Virus Type 1 with a Bead-Based Sandwhich Hybridization Format”Proc. Natl. Acad. Sci.(USA) 86:1173-1177 (1989).
Landegren, et al., “A Ligase-Mediated Gene Detection Technique”Science241:1077-1080 (1988).
Mendes, et al., “Antibodies in CFTR Studies”, Journal of Cystic Fibrosis, 3: 69-72, (2004).
Newton, et al., “Analysis of any Point Mutation in DNA. The Amplification Refractory Mutation System (ARMS)”Nucleic Acids Res.17:2503-2516 (1989).
Nickerson, et al., “Automated DNA Diagnostics Using an ELISA-Based Oligonucleotide Litigate Assay”Proc. Natl. Acad. Sci. USA87:8923-8927 (1990).
Okayama, et al., “Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification”, J. Lab. Clin. Med., 114:105-113, (1989).
Piggee, et al., “Capillary Electrophoresis for the Detection of Known Point Mutations by Single-Nucleotide Primer Extension and Laster-Induced Fluorescence Detection”Journal of Chromatography A781:367-375 (1997).
Poddar, S.K., “Symmetric vs Asymmetric PCR and Molecular Beacon Probe in the Detection of a Target Gene of Adenovirus”Molec. and Cell. Probes14:25-32 (2000).
Sarkar, et al., “Characterization of Polymerase Chain Reaction Amplification of Specific Alleles”Anal. Biochem.186:64-68 (1990).
Sellner, et al., “MLPA and MAPH: New Techniques for Detection of Gene Deletions”Human Mutation23:413-419 (2004).
Strom, et al., “Extensive sequencing of the cystic fibrosis transmembrane regulator gene: Assay validation and unexpected benefits of developing a comprehensive test”, Genetics in Medicine, 5(1):9-14, (2003).
Wall, et al. “A 31-Mutation Assay for Cystic Fibrosis Testing in the Clinical Molecular Diagnostics Laboratory”Human Mutation5(4):333-338 (1995).
Walker, et al., “Isothermal in Vitro Amplification of DNA by a Restriction Enzyme/DNA Polymerase System”Proc. Natl. Acad. Sci. USA89:392-396 (1992).
Walker, et al., “Production and characterisation of monoclonal and polyclonal antibodies to different regions of the cystic fibrosis transmembrane conductance regulator (CFTR): detection of immunologically related proteins”, Journal of Cell Science, vol. 108, pp. 2433-2444, (1995).
Wu, et al., “Allele-Specific Enzymatic Amplification of β-Globin Genomic DNA for Diagnosis of Sickle Cell Anemia”Proc. Natl. Acad. Sci. USA86:2757-2760 (1989).
Zielenski, et al., “Genomic DNA Sequence of the Cystic Fibrosis Transmembrane Conductane Regulator (CFTR) Gene”Genomics10:214-228 (1991).
Chunduru Suryaprabha
Foley & Lardner LLP
Quest Diagnostics Investments Incorporated
LandOfFree
Cystic fibrosis transmembrane conductance regulator gene... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cystic fibrosis transmembrane conductance regulator gene..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cystic fibrosis transmembrane conductance regulator gene... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4168033